Logo

Synapse Biomedical Receives FDA Emergency Use Authorization fo...

OBERLIN, Ohio, April 15, 2020 /PRNewswire-AsiaNet/ -- -- TransAeris(R) Diaphragm Pacing System (DPS) Could Cut Mechanical Ventilation Time by More Than 25%, Freeing up Vital Equipment, ICU Beds and Clinical Resources. Synapse Biomedical, Inc. (www.synapsebiomedical.com) has received FDA Emergency...

Authors: LATEST ASIANET NEWS RELEASES

Read more

Asian Spectator by NewsServices.com - office@NewsServices.com - 1300 660 660